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Abstract
Background: Tobacco smoke exposure (TSE) is a worldwide health problem and it is considered a risk factor for
pregnant women’s and children’s health, particularly for respiratory morbidity during the first year of life. Few
significant birth cohort studies on the effect of prenatal TSE via passive and active maternal smoking on the
development of severe bronchiolitis in early childhood have been carried out worldwide.
Methods: From November 2009 to December 2012, newborns born at ≥33 weeks of gestational age (wGA) were
recruited in a longitudinal multi-center cohort study in Italy to investigate the effects of prenatal and postnatal TSE,
among other risk factors, on bronchiolitis hospitalization and/or death during the first year of life.
Results: Two thousand two hundred ten newborns enrolled at birth were followed-up during their first year of life.
Of these, 120 (5.4 %) were hospitalized for bronchiolitis. No enrolled infants died during the study period.
Prenatal passive TSE and maternal active smoking of more than 15 cigarettes/daily are associated to a significant
increase of the risk of offspring children hospitalization for bronchiolitis, with an adjHR of 3.5 (CI 1.5–8.1) and of 1.7
(CI 1.1–2.6) respectively.
Conclusions: These results confirm the detrimental effects of passive TSE and active heavy smoke during
pregnancy for infants’ respiratory health, since the exposure significantly increases the risk of hospitalization for
bronchiolitis in the first year of life.
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Background
Tobacco smoke exposure (TSE) is a worldwide health
problem and a risk factor for children’s health par-
ticularly for respiratory morbidity during the first
years of life [1–6]. TSE during pregnancy, including
both passive and active smoke, is also a well known
risk factor for several complications of pregnancy and
for respiratory disorders of offspring during the first
months of life [1–3].
Moreover, TSE has been associated to a more severe
clinical course of bronchiolitis [4-6], often requiring
hospitalization. Viral bronchiolitis is a common lower
respiratory tract infection in infants and often requires
hospitalization in children younger than 2 years of age.
It is characterized by wheezing and mucous plugging,
resulting in airway obstruction [7].
Although the detrimental effects of TSE for children’s
health are well known, the exposure continues to involve
a large amount of infants worldwide: in 2004 about 40 %
of the entire pediatric population was exposed to
second-hand smoke, with 166,000 of the 5,939,000 re-
spiratory infections and deaths due to this exposure in
children younger than 5 years [8]. In several countries,
smoke banning laws have been promoted with the aim
to reduce the exposure in public places and subsequently
protect high risk people, such as pregnant women, new-
borns and young infants from passive TSE. The intro-
duction of smoke-free legislation in many countries has
been related to about a ten percent decrease in preterm
* Correspondence: silviavandini@gmail.com
2Neonatology Unit, S.Orsola-Malpighi Hospital, University of Bologna, Via
Massarenti 11 40138, Bologna, Italy
Full list of author information is available at the end of the article
© 2015 Lanari et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lanari et al. Respiratory Research  (2015) 16:152 
DOI 10.1186/s12931-015-0312-5
births (10.4 %) and in hospital admissions for asthma
(10.1 %) [9].
In Italy, the estimated number of smokers is 11.6 mil-
lion (7.1 million men and 4.5 million women), according
to a national report considering the entire Italian popu-
lation [10]. A comprehensive smoking ban was intro-
duced in 2003 to prohibit smoking in public places,
causing a 6.3 % decrease of active smokers in the Italian
population [11].
In an Italian cohort study of infants younger than
2 years hospitalized for acute LRTI [12], postnatal TSE
results to be a significant risk factor for hospitalization.
To our knowledge, few birth cohort studies [13–16]
have been carried out that focus on the effect of prenatal
TSE via passive and active maternal smoking on the de-
velopment of lung diseases in childhood, which provide
reports that smoke exposure in early life may increase
the lung susceptibility to air pollution [16] and that pre-
natal TSE is related to an earlier onset of asthma. More-
over, no recent birth cohort study has investigated the
effect of prenatal and early postnatal TSE on the risk of
hospitalization for bronchiolitis during the first year of
life.
The aim of the present study is to determine the ef-
fects of prenatal passive and active TSE and early post-
natal TSE with other risk factors for hospitalization for
bronchiolitis in a large cohort of preterm newborns at
GA 33 weeks or more and full term newborns.
Methods
Study subjects
This study was promoted by the Italian Society of Neo-
natology with the National Research Council and in-
volved thirty neonatology units, registering 1,000 births
or more each year, in the northern, central and southern
areas of Italy. The study was approved by each one of
the ethical committees of the participating centres. Par-
ents in the study provided their signed informed consent
to participate in the study; details on the modalities of
recruitment and of data collection have been described
elsewhere [17, 18]. Briefly, all consecutive newborns at
33–34 weeks gestational age (wGA) seen in a recruit-
ment period lasting 1 year from the first enrolment by
the participating centres were enrolled. For each en-
rolled newborn of 33–34 wGA, two newborns of the
same sex and with the nearest date of birth were en-
rolled: one of 35–37 wGA and one of >37 wGA. The en-
rolment was carried out according to GA with the aim
to analyse potential differences related to GA. Exclusion
criteria were: life expectancy shorter than 6 months; par-
ticipation in clinical studies on pharmacological or surgi-
cal interventions; haemodynamically significant
congenital heart diseases or chronic lung diseases; pro-
grammed or administered RSV prophylaxis with a
humanized monoclonal antibody (palivizumab). Ex-
cluded infants were those not residing in the geograph-
ical catchment area of the enrolling neonatology unit
hospital.
Data collection
From November 1st 2009 to December 30th 2012, 2,314
newborns (1,113 females and 1,201 males) were enrolled
in the study. At time of birth, parents were interviewed
with a structured questionnaire on their demographics,
health and socio-demographic status, living conditions
and TSE. In addition, information on pregnancy, delivery
and newborn conditions given by the parents were inte-
grated, when necessary, with the information contained
in the clinical record form. The same physician in each
center collected the data using a standard record form.
After discharge, two structured follow-up phone inter-
views with the child’s parents were carried out by trained
interviewers. The first interview took place during the
infective respiratory epidemic season (in Italy from No-
vember to March [19]), the second at the 12 month after
birth. The interviews collected data on possible environ-
mental risk conditions for bronchiolitis, including house-
hold health and crowded living conditions, daily contact
with siblings or other children and day care attendance
and lack of or early interruption or no breastfeeding.
Assessment of pre- and postnatal TSE
Exposure to tobacco smoke during pregnancy was
assessed by asking the mother whether she smoked
during pregnancy, and if so, how many cigarettes per
day and whether the father or other people smoked
regularly in her presence. The information collected
was then collapsed into a single variable with the fol-
lowing four categories for prenatal TSE: no; only pas-
sive; active with 1–15 cigarettes per day and active
with 16 or more cigarettes per day.
Exposure to tobacco smoke after birth was assessed
during the two follow-up interviews by asking the
parents if the mother, father or other people in the
household smoked inside and/or outside of the child’s
living environment in the first year of life. Similarly
as for prenatal TSE, the information collected was
collapsed into a single variable; postnatal TSE with
the following three categories: no; outside the child’s
living environment and in the child’s living environ-
ment. Finally, a third variable was constructed: any
tobacco smoke exposure that was comprehensive of
any prenatal or postnatal exposure.
Outcome
The main outcome of this study was hospitalization
and/or death due to bronchiolitis during the first year of
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life, as classified by the ICD-9 code 466.1 (codifying for
acute bronchiolitis) [20].
During the two follow up interviews, parents were
asked about hospitalizations of the child. If the child was
referred as having been hospitalized, further confirm-
ation was obtained by retrieval of the hospital record
forms or by direct contact with the physician who was
responsible of the infant during hospitalization.
Statistical analysis
The cumulative time-dependent risks of hospitalization
for bronchiolitis during the first year of life of the infants
were calculated with survival analysis. Relative risks were
estimated as hazard ratios (HR) with 95 % Confidence
Intervals (CI) calculated from the standard errors de-
rived from Cox’s proportional hazard model [21]. Multi-
variate analyses were carried out to estimate the
independent contribution of each considered factor to
the risk of bronchiolitis.
In order to identify further potential predictors of
bronchiolitis hospitalization besides exposure to tobacco
smoke, we used a two-step approach. Firstly, we per-
formed a multivariate analysis within the prenatal and
the neonatal variables considered as potential risk factors
for bronchiolitis (Table 1 of the Additional file 1). The
variables significantly associated with the outcome (the
level of statistical significance was set at p-value = 0.05),
served for defining the exposure to pre and perinatal risk
factors of bronchiolitis. Children were considered pre-
natally exposed (father suffering from respiratory dis-
eases, no recourse to assisted reproductive technologies
and use of corticosteroid therapy for lung maturation)
and/or perinatally exposed (male sex, singleton delivery
and surfactant therapy), when at least one of these sig-
nificant risk factors was present. Pre and perinatal expo-
sures were then entered in the final multivariable
analysis as single dichotomous variables. Although non
statistically significant in the first step of the analysis,
age of the mother (continuous variable), parents’ level of
education in years of completed school (both less or
equal to 8 years, at least one more than 8 and less or
equal to 13 years, both more than 13 years) and weeks
of gestational age were considered as potential con-
founding variables and were entered in the final multi-
variable analysis.
We considered also well-known environmental risk
factors (RFs) of bronchiolitis as single covariates: expos-
ure to epidemic season (defined as children living for at
least one of the first 3 months of life during the calendar
period between November to March); no breastfeeding
(i.e. feeding of the newborn without breast milk beyond
the age of 1 month); presence of siblings or children
(less than 10 years old) sharing the same living environ-
ments; crowded living conditions (i.e. the presence of
five or more people older than 10 years in the living en-
vironment of the newborn) and day care attendance.
Sample size was calculated by fixing a predefined pre-
cision of the estimate of the absolute risk of
hospitalization and/or death for bronchiolitis induced or
not by RSV during the first year of life. Assuming that
the risk of hospitalization for bronchiolitis during the
first year of life was about 7 % a sample size of 2,500
newborns could provide a 95 % confidence interval (95
% CI) of 6.0 to 8.1 % which is largely consistent with a
random error of less than 20 %.
The level of statistical significance was set for all the
analysis at p = 0.05.
The software package used was IBM SPSS Statistics
for Windows version 21.0 (Armonk, NY, IBM Corp.).
Results
Of the 2,314 newborns, 104 were not available for the
first scheduled follow-up interview and thus the
remaining 2,210 (1,150 male and 1,060 female) were
considered for this analysis. All of the infants survived
the entire follow-up period. One hundred and 20 new-
borns (5.4 %) were hospitalized for bronchiolitis during
the study period, most frequently during the very early
period of life (54 % within the 3 month of life). In only
31 newborns hospitalized for bronchiolitis a laboratory
test was carried-out resulting positive for RSV in 26
(83 %) cases. Parental socio-demographic and infants’
characteristics are reported in Table 1 by hospitalization
for bronchiolitis. Low level of parents’ education, low ges-
tational age and all the considered prenatal, neonatal and
postnatal risk conditions were more frequent in infants
hospitalized for bronchiolitis. Moreover, any exposure (pre
and post-natal) to tobacco smoke was more frequently
registered in children who were hospitalized for
bronchiolitis
The different exposures and characteristics of the in-
fants according to exposure to tobacco smoke during
the prenatal and postnatal life are reported in Table 2.
TSE (both prenatal and postnatal) was more frequent in
babies born to parents with only primary education.
Mothers smoking more than 15 cigarettes per day dur-
ing pregnancy more frequently had newborns with low
gestational ages. Maternal smoking of more than 15 cig-
arettes per day during pregnancy was associated with an
increase of non-breastfeeding of the newborn. Presence
of siblings was associated with TSE both of the mother
during pregnancy and of the newborn in postnatal life
period. Also, living in crowded living conditions was
more frequent for newborns exposed to smoke in pre-
natal and postnatal periods.
Table 3 and Fig. 1 describe the association of tobacco
smoke exposure and all considered risk factors, with the
risk of hospitalization for bronchiolitis during the first
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year of life. At univariate analysis, the exposure to any
tobacco smoke was associated with a 40 % increased risk
of hospitalization (HR = 1.4, 95 % CI 1.0–2.1). When ac-
counting for all the other considered variables in multi-
variable analysis, the risk was still increased however lost
statistical significance (HR 1.3, 95 % CI 0.9–1.9). More-
over, when considering exposure to prenatal tobacco
smoke, having a mother smoking more than 15 ciga-
rettes every day or a mother exposed to second hand
smoke were associated with a significant risk increase of
3.5 (CI 1.5–8.1) and of 1.7 (1.1–2. 6), respectively. In
multivariable analysis these risks remained substantially
equal in size and direction. As far as tobacco exposure
in postnatal period is concerned, only small non-
significant risk increases were observed in univariate
analysis that were no longer present in multivariable
analysis. Among the other considered variables, the most
remarkable results from the multivariable analysis were
a negative association with mother’s age and with in-
creasing gestational age at birth, positive significant
associations with all the environmental risk conditions
and finally, no significant association with parent’s
educational level and with prenatal or perinatal risk
conditions.
Discussion
The results of this study demonstrate that passive TSE
and heavy active smoke exposure during pregnancy in-
creases the risk of hospitalization for bronchiolitis dur-
ing the first year of life, and in particular, during the first
3 months of life, while postnatal TSE does not signifi-
cantly increase the risk in our cohort. These results
could be explained by the fact that passive exposure is
less preventable than active smoking, which is often
interrupted during pregnancy. Our results suggest that
the detrimental effect on lung development and subse-
quent higher risk for hospitalization may depend mostly
on prenatal exposure rather than to postnatal TSE. This
could be due to the fact that most mothers quit smoking
during the first trimester, however by this time, the pul-
monary system reaches its full development and there-
fore deleterious influences could play a major role.
The detrimental effects of TSE during pregnancy on
fetal growth and lung development have been widely
studied. Fetal TSE increases the risk for intrauterine
growth retardation, prematurity and impaired lung de-
velopment through placental vascular damage induced
by cotinine, which causes placental insufficiency and nu-
tritional deprivation that may interfere with growth and
Table 1 Socio-Demographic, pre-, neo-, and post- natal conditions of healthy and bronchiolitis hospitalized infants
Hospitalization for bronchiolitis
Total No Yes
Socio demographic characteristics of parents
Mother’s Age (y, mean ± SD) 33.6 ± 5.3 33.6 ± 5.3 33.2 ± 5.5
Parents’ Educational Level
Primary, N. (%) 270 251 (12.0) 19 (15.8)
High, N. (%) 1521 1440 (68.9) 81 (67.5)
Graduate, N. (%) 419 399 (19.1) 20 (16.7)
Gestational age at birth
Weeks
33–34, N. (%) 737 683 (32.7) 54 (45.0)
35–37, N. (%) 767 726 (34.7) 41 (34.2)
> 37, N. (%) 706 681 (32.6) 25 (20.8)
Risk conditions
Prenatal Risk 2092 1974 (94.4) 118 (98.3)
Neonatal Risk 1945 1837 (87.9) 108 (90.0)
Environmental risk conditions
Exposure to Epidemic Season 1323 1234 (59.0) 89 (74.2)
No breastfeeding 482 440 (21.1) 42 (35.0)
Presence of siblings 900 820 (39.2) 80 (66.7)
Crowded Living Conditions 227 200 (9.6) 27 (22.5)
Day Care Attendance 357 331 (15.8) 26 (21.7)
Any smoke exposure 1043 976 (46.7) 67 (55.8)
Total 2210 2090 (94.6) 120 (5.4)
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lung maturation [22] and through epigenetic mecha-
nisms. [23–25] These mechanisms are determined by
several metabolites derived from tobacco smoke that
have low molecular weight and are able to cross the pla-
centa and induce oxidative damage, mitochondrial dys-
function and chronic hypoxia leading to genetic
modifications that affect fetal growth and development
[26, 27]. Appropriate development of fetal lung requires
adequate nutritional intake and placental blood flow as
well as the precisely timed gene expression that is, in
part, dependent from the extensive combination of DNA
methylation and histone modifications. Thus the inter-
ference with the normal epigenetic modifications during
fetal life can alter gene transcription and may alter lung
growth and function [24, 27].
Recently, some authors have observed that fetal growth
is also influenced by maternal grandmother smoking
habits during pregnancy [28, 29] of non-smoking mothers,
likewise, the attitude toward smoking of the grandmother
is associated to an elevated risk of asthma in children [30,
31]. The mechanism hypothesized for these effects include
a cascade of metabolic knock-on effects involving initial
somatic metabolic in utero “programming” of the mother
and a direct effect of grandmaternal smoking on oogenesis
of her own daughter when she was a fetus [32, 33]. It is
possible that by modifying DNA methylation patterns in
the fetal oocytes, tobacco-derived metabolites may inter-
fere with both immune function and xenobiotic detoxifi-
cation mechanisms in the offspring, resulting in an
increased susceptibility to respiratory diseases affecting
the subsequent generation.
In our study, we found that active smoking during preg-
nancy has an effect on the risk for bronchiolitis
hospitalization that is dose-dependent. We defined heavy
smoking mothers who smoked more than 15 cigarettes/
day, as previously done in another study [34], with the
aim to emphasize the effect of a discrete number of ciga-
rettes. The dose-dependency of active smoking during
Table 2 Association of infants’ pre- and post- natal TSE with socio-demographic, pre-, neo-, post- natal conditions and bronchiolitis
hospitalization
Prenatal smoking exposure Postnatal smoking exposure
Passive Active maternal smoking
Newborn and parents’ characteristics Total None maternal
smoking
≤15
cig/day
>15
cig/day
None Out of living
environment
In living
environment
Socio demographic characteristics
of parents
Mother’s Age 33.6 ± 5.3 33.9 ± 5.2 32.9 ± 5.1 32.5 ± 5.8 34.0 ± 5.5 34.1 ± 5.2 32.8 ± 5.3 33.5 ± 5.5
(y, mean ± SD)
Parents’ Educational Level
Primary, N. (%) 270 159 (9.7) 50 (14.9) 50 (26.3) 11 (27.5) 115 (8.8) 136 (17.1) 19 (17.6)
High, N. (%) 1521 1122 (68.2) 243 (72.3) 128 (67.4) 28 (70.0) 885 (67.7) 564 (71.0) 72 (66.7)
Graduate, N. (%) 419 363 (22.1) 43 (12.8) 12 (6.3) 1 (2.5) 308 (23.5) 94 (11.8) 17 (15.7)
Gestational Age at birth
Weeks
33–34, N. (%) 737 559 (34.0) 102 (30.4) 60 (31.6) 16 (40.0) 427 (32.6) 273 (34.4) 37 (34.3)
35–37, N. (%) 767 560 (34.1) 114 (33.9) 81 (42.6) 12 (30.0) 447 (34.2) 279 (35.1) 41 (38.0)
> 37, N. (%) 706 525 (31.9) 120 (35.7) 49 (25.8) 12 (30.0) 434 (33.2) 242 (30.5) 30 (27.8)
Risk conditions
Prenatal Risk 2092 1551 (94.3) 323 (96.1) 180 (94.7) 38 (95.0) 1231 (94.1) 760 (95.7) 101 (93.5)
Neonatal Risk 1945 1445 (88.5) 299 (89.0) 165 (86.8) 36 (90) 1137 (86.9) 712 (89.7) 96 (88.9)
Environmental risk conditions
Exposure to Epidemic Season 1323 998 (60.7) 196 (58.3) 108 (56.8) 21 (52.5) 790 (60.4) 455 (57.3) 78 (72.2)
No Breastfeeding 482 352 (21.4) 70 (20.8) 45 (23.7) 15 (37.5) 289 (22.1) 169 (21.3) 24 (22.2)
Siblings 900 644 (39.2) 145 (43.2) 89 (46.8) 22 (55.0) 520 (39.8) 330 (41.6) 50 (46.3)
Crowded Living 227 160 (9.7) 35 (10.4) 25 (13.2) 7 (17.5) 141 (10.8) 68 (8.6) 18 (16.7)
Day Care Atten dance Attendance 357 265 (16.1) 43 (12.8) 43 (22.6) 6 (15.0) 221 (16.9) 117 (14.7) 19 (17.6)
Hospitalizations for bronchiolitis (%) 120 (5.4) 77 (4.7) 26 (7.7) 11 (5.8) 6 (15.0) 65 (5.0) 47 (5.9) 8 (7.4)
TOTAL 2210 1644 336 190 40 1308 794 108
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pregnancy was observed also for growth restriction in pre-
vious studies [27, 35]. This result suggests that a reduction
in the number of smoked cigarettes, particularly in heavy
smokers, may reduce the risk for hospitalization in infants.
Moreover, active smoking during pregnancy was associ-
ated to lower GA, confirming the effect of tobacco smoke
on the risk of preterm birth; the effect of active smoke
however was confirmed by the multivariate analysis, es-
tablishing that it is independent from GA.
To date, only a few studies have distinguished be-
tween prenatal and postnatal TSE and their conse-
quences on respiratory health in early life [36, 37].
The study by Jaakkola et al. [38] demonstrates the
strongest adverse effects of tobacco smoke on the
lower respiratory tract when smoking takes place dur-
ing pregnancy. In prenatally exposed children, postna-
tal exposure from either parent did not significantly
increase the occurrence of the respiratory health out-
comes analysed by Fuentes-Leonarte et al. [39].
TSE in infants may cause bronchial hyper-reactivity and
direct toxic and irritant effects on the lungs and the air-
ways [23]. TSE may increase the susceptibility to patho-
gens due to impaired protective mechanisms of the
airways and bronchial tree, such as mucociliary clearance
Table 3 Crude and adjusted hazard ratios for risk factors for hospitalization for lower respiratory tract infections in the first year of
life
Hazard ratios (95 % CI)
Crude HR p-value Adjusted HR p-value
Tobacco smoke exposure
Any 1.4 (1.0–2.1) 0.050 1.3 (0.9–1.9) 0.131
Prenatal
None 1 1
Mother smoking ≤15 cigarette 1.3 (0.7–2.4) 0.476 1.0 (0.5–2.0) 0.964
Mother smoking >15 cigarette 3.5 (1.5–8.1) 0.003 2.4 (1.0–5.7) 0.052
Mother exposed to passive smoke 1.7 (1.1–2.6) 0.021 1.8 (1.1–2.9) 0.024
Postnatal
None 1 1
Out of living environment 1.2 (0.8–1.8) 0.343 1.0 (0.6–1.5) 0.869
In living environment 1.5 (0.7–3.1) 0.275 0.9 (0.4–1.9) 0.707
Socio demographic characteristics of parents
Mother’s Age (y) 0.9 (0.8–1.1) 0.344 0.8 (0.7–1.0) 0.055
Parents’ Educational Level
Primary 1 1
High 0.7 (0.5–1.2) 0.256 1.0 (0.6–1.7) 0.956
Graduate 0.7 (0.4–1.3) 0.215 1.1 (0.6–2.3) 0.727
Gestational Age at birth
Weeks
33–34 1 1
35–37 0.7 (0.5–1.1) 0.114 0.7 (0.4–1.0) 0.046
> 37 0.5 (0.3–0.8) 0.002 0.5 (0.3–0.8) 0.002
Risk conditions
Prenatal 3.4 (0.8–13.8) 0.086 2.3 (0.6–9.7) 0.242
Perinatal 1.2 (0.7–2.2) 0.497 1.4 (0.7–2.5) 0.315
Environmental risk conditions
Exposure to Epidemic Season 2.0 (1.3–3.0) 0.001 1.9 (1.2–2.8) 0.003
Breastfeeding 2.0 (1.4–2.9) 0.000 1.8 (1.2–2.7) 0.003
Siblings 3.0 (2.1–4.4) 0.000 3.2 (2.2–4.8) 0.000
Crowded living Conditions 2.6 (1.7–4.1) 0.000 2.5 (1.6–3.9) 0.000
Day care attendance 1.4 (0.9–2.2) 0.113 1.7 (1.1–2.7) 0.015
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[4]. Infants of women smokers are more likely to have di-
minished lung function soon after birth, which could con-
tribute to the development of acute respiratory outcomes
such as infections as its concomitant symptoms. [40] We
found that postnatal TSE during the first year of life was
associated to a slightly higher hospitalization rate without
reaching the statistical significance. This limited time span
may underestimate the total effect of exposure since asses-
sing respiratory tract infections at older ages might show
stronger effects. However, our results are consistent with
those obtained by Duijts et al. [41] which analysed a pre-
natally enrolled birth-cohort and showed weak evidence
for an association of maternal smoking in the early post-
natal period with bronchiolitis in infants in the first
6 months of life [41].
The strength of the present study is the prospective
analysis of a large birth cohort and the inclusion of a
large number of other variables that may interact with
TSE in the increase of bronchiolitis severity and
hospitalization.
One of the limits of the present study is that TSE was
assessed on subjective parent report, however other
studies reported good agreement between self-reported
exposure and biochemical markers dosed in the
household environment and in urine samples [42–44]..
Another limitation is related to the fact that we consid-
ered only hospitalizations for bronchiolitis and therefore
factors related to both the propensity to recur to
hospitalization and to TSE, such as socio-cultural condi-
tions of the parents, which may act as confounders of
our results. Nevertheless, we hold the conviction that
the universal coverage of the Italian National Health Ser-
vice, which is free for every Italian citizen, guarantees
virtually equal access to hospital medical care to every-
one in cases concerning severe bronchiolitis. In our co-
hort study, heavy active smoking during pregnancy was
associated to lack of breastfeeding and to crowded living
conditions, and it was more frequent if parents had only
primary level education. This data could be explained by
the lower attention paid by a subgroup of women during
pregnancy to campaigns promoting prenatal and neo-
natal health. This is an interesting note as it could be
useful to identify pregnant women that may require an
implementation of counselling to promote breastfeeding
and to improve the overall living conditions of their
newborns.
Our study supports the evidence of the strongest ef-
fects of TSE during pregnancy and supports that
Fig. 1 Crude and Adjusted Hazard Ratios (HRs) for Prenatal and Postnatal Tobacco Smoke Exposure for bronchiolitis Hospitalization in the First
Year of Life. Adjusted for mother’s age (y), parents’ educational level, wGA, prenatal risk conditions, neonatal risk conditions, exposure to epidemic
season, breastfeeding, siblings, crowded living, day care attendance
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smoking cessation campaigns should target all family
and household members as well as colleagues in
workplaces of non-smoking expecting mothers. More-
over, the knowledge of the detrimental effects of TSE
on infants could increase awareness regarding the im-
portance of reducing second-hand smoke exposure,
not only in public places but in private households as
well as.
Health professionals play a pivotal role in promot-
ing the cessation of active smoking and passive smoke
exposure in pregnant women and more should be
done: a recent Australian study [45] reported that less
than half pregnant women were discourage to stop
smoking by healthcare professionals.
Data obtained in the present study could be used
by practitioners, obstetricians, neonatologists, pediatri-
cians, midwives and other healthcare professionals in
order to improve the information provided during
counselling to pregnant women and new parents
about the risks of TSE on their offspring. Extended
follow up of this cohort of children will allow us to
establish whether these exposures are important pre-
dictors of asthma in later childhood and a possible
cause of permanent impairment of pulmonary func-
tion. Moreover, further investigations could be useful
to clarify the effect of TSE in pediatric patients with
other well known risk factors for hospitalization for
bronchiolitis (i.e., prematurity, congenital heart dis-
ease, chronic lung disease, immunodeficiency, neuro-
muscular disease.
Conclusions
Bronchiolitis is a major cause of hospitalization for infants
and passive and active maternal TSE during pregnancy
seems to be significant RFs that can be modified. Accord-
ing to the tendencies found in this study, the elimination
of smoking during pregnancy and the avoidance of
second-hand TSE in the environment where pregnant
women live are mandatory in order to reduce morbidity of
newborns and young infants, also in the presence of other
non-modifiable RFs for bronchiolitis. Moreover, since
women are more likely to quit smoking during pregnancy
than at any other time, there are efforts to increase
motivation and help women who are planning to
conceive to stop smoking at the procreative phase of
their life or during pregnancy. Finally, studies on
respiratory tract infections in infants at a later age
are necessary to examine the long-term effects of
maternal TSE during and after pregnancy. The results
of the present study will be used by the Italian
Neonatology Society, that supported the study, to
improve counselling to families and pregnant women
to reduce tobacco smoke exposure.
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